These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 8670733)
1. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro. Tirado-Angel J; Gabriel MM; Wilson LA; Ahearn DG Curr Eye Res; 1996 Feb; 15(2):225-8. PubMed ID: 8670733 [TBL] [Abstract][Full Text] [Related]
2. Resistance, biguanide sorption and biguanide-induced pentose leakage during encystment of Acanthamoeba castellanii. Turner NA; Russell AD; Furr JR; Lloyd D J Appl Microbiol; 2004; 96(6):1287-95. PubMed ID: 15139921 [TBL] [Abstract][Full Text] [Related]
4. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Narasimhan S; Madhavan HN; K LT Cornea; 2002 Mar; 21(2):203-5. PubMed ID: 11862096 [TBL] [Abstract][Full Text] [Related]
5. Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii. Moon EK; Choi HS; Kong HH; Quan FS Exp Parasitol; 2018 Aug; 191():31-35. PubMed ID: 29885293 [TBL] [Abstract][Full Text] [Related]
6. Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba. Alizadeh H; Neelam S; Cavanagh HD Eye Contact Lens; 2009 Jan; 35(1):1-5. PubMed ID: 19125040 [TBL] [Abstract][Full Text] [Related]
7. The lethal effects of biguanides on cysts and trophozoites of Acanthamoeba castellanii. Khunkitti W; Lloyd D; Furr JR; Russell AD J Appl Bacteriol; 1996 Jul; 81(1):73-7. PubMed ID: 8675485 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity. Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604 [TBL] [Abstract][Full Text] [Related]
9. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Lamy R; Chan E; Good SD; Cevallos V; Porco TC; Stewart JM Clin Exp Ophthalmol; 2016 Apr; 44(3):181-7. PubMed ID: 26355273 [TBL] [Abstract][Full Text] [Related]
10. Acanthamoeba castellanii: growth, encystment, excystment and biocide susceptibility. Khunkitti W; Lloyd D; Furr JR; Russell AD J Infect; 1998 Jan; 36(1):43-8. PubMed ID: 9515667 [TBL] [Abstract][Full Text] [Related]
11. Effects of biocides on Acanthamoeba castellanii as measured by flow cytometry and plaque assay. Khunkitti W; Avery SV; Lloyd D; Furr JR; Russell AD J Antimicrob Chemother; 1997 Aug; 40(2):227-33. PubMed ID: 9301988 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini. Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Borazjani RN; May LL; Noble JA; Avery SV; Ahearn DG Appl Environ Microbiol; 2000 Mar; 66(3):1057-61. PubMed ID: 10698771 [TBL] [Abstract][Full Text] [Related]
14. Biguanide-induced changes in Acanthamoeba castellanii: an electron microscopic study. Khunkitti W; Hann AC; Lloyd D; Furr JR; Russell AD J Appl Microbiol; 1998 Jan; 84(1):53-62. PubMed ID: 15244057 [TBL] [Abstract][Full Text] [Related]
15. In vitro Evaluation the Efficacy of Some New Plant Extracts and Biocides on the Viability of Acanthamoeba castellanii. Abdullah Hamad A Protist; 2023 Jun; 174(3):125966. PubMed ID: 37229821 [TBL] [Abstract][Full Text] [Related]
16. Aspects of the mechanisms of action of biguanides on trophozoites and cysts of Acanthamoeba castellanii. Khunkitti W; Lloyd D; Furr JR; Russell AD J Appl Microbiol; 1997 Jan; 82(1):107-14. PubMed ID: 9147866 [TBL] [Abstract][Full Text] [Related]
17. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity. Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179 [TBL] [Abstract][Full Text] [Related]
18. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234 [TBL] [Abstract][Full Text] [Related]
19. Acanthamoeba polyphaga strain age and method of cyst production influence the observed efficacy of therapeutic agents and contact lens disinfectants. Hughes R; Heaselgrave W; Kilvington S Antimicrob Agents Chemother; 2003 Oct; 47(10):3080-4. PubMed ID: 14506012 [TBL] [Abstract][Full Text] [Related]
20. Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Lee JE; Oum BS; Choi HY; Yu HS; Lee JS Cornea; 2007 Jul; 26(6):736-41. PubMed ID: 17592327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]